Literature DB >> 19525357

Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States: findings from the nationwide inpatient sample.

Brian Park1, Louis Messina1, Phong Dargon1, Wei Huang2, Rocco Ciocca3, Frederick A Anderson4.   

Abstract

BACKGROUND: Pulmonary embolism (PE) has been cited as the most common preventable cause of death in hospitalized patients. The objectives of this study were to determine recent trends in clinical outcomes and resource utilization for hospitalized patients with a clinically recognized episode of acute PE.
METHODS: Patients with primary or secondary PE who had been discharged from US acute care hospitals were identified from the Nationwide Inpatient Sample during the 8-year period between 1998 and 2005. The major clinical outcomes assessed included hospital mortality and length of hospitalization. To assess resource utilization for the treatment of PE, average hospital charges for these admissions were assessed, normalized to 2005 US dollars, and adjusted to reflect the US consumer price index.
RESULTS: Between 1998 and 2005, the number of patients with primary or secondary PE on discharge from the hospital increased from 126,546 to 229,637; hospital case fatality rates for these patients decreased from 12.3 to 8.2% (p < 0.001); length of hospital stay decreased from 9.4 days to 8.6 days (p < 0.001); and total hospital charges increased from $25,293 to $43,740 (p < 0.001).
CONCLUSIONS: Between 1998 and 2005, significant improvements were observed in outcomes for patients hospitalized for clinically recognized PE, including decreases in mortality and length of hospital stay. Charges for this hospital care increased during this time period.

Entities:  

Mesh:

Year:  2009        PMID: 19525357     DOI: 10.1378/chest.08-2258

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  34 in total

1.  Transcatheter pulmonary embolectomy after fontan.

Authors:  Rachel D Torok; Gregory A Fleming; Kevin D Hill
Journal:  Catheter Cardiovasc Interv       Date:  2015-07-08       Impact factor: 2.692

2.  Rationale, Design and Methodology of the Computerized Registry of Patients with Venous Thromboembolism (RIETE).

Authors:  Behnood Bikdeli; David Jimenez; Mayra Hawkins; Salvador Ortíz; Paolo Prandoni; Benjamin Brenner; Hervé Decousus; Frederick A Masoudi; Javier Trujillo-Santos; Harlan M Krumholz; Manuel Monreal
Journal:  Thromb Haemost       Date:  2018-01-05       Impact factor: 5.249

3.  Claims-based or clinical models for predicting 90-day post-pulmonary embolism outcomes.

Authors:  Cecilia Becattini; Giancarlo Agnelli
Journal:  Intern Emerg Med       Date:  2017-05-22       Impact factor: 3.397

4.  CT pulmonary angiography after total joint arthroplasty: overdiagnosis and iatrogenic harm?

Authors:  Michele R D'Apuzzo; Thomas C Keller; Wendy M Novicoff; James A Browne
Journal:  Clin Orthop Relat Res       Date:  2013-05-10       Impact factor: 4.176

5.  Management of pulmonary embolism with rheolytic thrombectomy.

Authors:  Lisa Ferrigno; Robert Bloch; Judson Threlkeld; Thomas Demlow; Raman Kansal; Riyad Karmy-Jones
Journal:  Can Respir J       Date:  2011 Jul-Aug       Impact factor: 2.409

6.  The impact of saddle embolism on the major adverse event rate of patients with non-high-risk pulmonary embolism.

Authors:  M K Kwak; W Y Kim; C W Lee; D W Seo; C H Sohn; S Ahn; K S Lim; M W Donnino
Journal:  Br J Radiol       Date:  2013-09-20       Impact factor: 3.039

Review 7.  Biochemical markers for the diagnosis of venous thromboembolism: the past, present and future.

Authors:  Giuseppe Lippi; Gianfranco Cervellin; Massimo Franchini; Emmanuel J Favaloro
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

8.  Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism: The Population-based Worcester VTE Study (1999 to 2009).

Authors:  W Huang; R J Goldberg; A T Cohen; F A Anderson; C I Kiefe; J M Gore; F A Spencer
Journal:  Thromb Res       Date:  2015-04-11       Impact factor: 3.944

9.  Metabolic syndrome increases risk of venous thromboembolism recurrence after acute deep vein thrombosis.

Authors:  Lauren K Stewart; Jeffrey A Kline
Journal:  Blood Adv       Date:  2020-01-14

10.  Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009).

Authors:  Wei Huang; Robert J Goldberg; Frederick A Anderson; Catarina I Kiefe; Frederick A Spencer
Journal:  Am J Med       Date:  2014-05-06       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.